Nosocomial H1N1 infection during 2010-2011 pandemic: A retrospective cohort study from a tertiary referral hospital

Journal of Hospital Infection

Volumn 81, Issue 3, 2012, Pages 202-205

  Veenith, T ^a   Sanfilippo, F ^a,b   Ercole, A ^a   Carter, E ^a   Goldman, N ^a   Bradley, P G ^a   Gunning, K ^a   Burnstein, R M ^a  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

Critical care unit; H1N1; Hospital acquired H1N1 influenza; Vaccine

Indexed keywords

OSELTAMIVIR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; DISEASE TRANSMISSION; FEMALE; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFECTION CONTROL; INFLUENZA A (H1N1); INTENSIVE CARE; MALE; MORTALITY; PANDEMIC INFLUENZA; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE; VACCINATION;

ADULT; AGED; COHORT STUDIES; CROSS INFECTION; FEMALE; HUMANS; INCIDENCE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PANDEMICS; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84862681317     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2012.04.010     Document Type: Article

References (10)

1. Miller R.R., Markewitz B.A., Rolfs R.T., et al. Clinical findings and demographic factors associated with ICU admission in Utah due to novel 2009 influenza A(H1N1) infection. Chest 2010, 137:752-758.
2. Simonds A.K., Hanak A., Chatwin M., et al. Evaluation of droplet dispersion during non-invasive ventilation, oxygen therapy, nebuliser treatment and chest physiotherapy in clinical practice: implications for management of pandemic influenza and other airborne infections. Health Technol Assessmnt 2010, 14:131-172.
3. Girard M., Tam J., Assossou O., Kieny M. The 2009 A (H1N1) influenza virus pandemic: a review. Vaccine 2010, 28:4895-4902.
4. Esposito S., Cecinati V., Russo F.G., Principi N. Influenza vaccination in children with cancer receiving chemotherapy. Hum Vaccin 2009, 5:430-432.
5. Torii Y., Kimura H., Ochi N., et al. Immunogenicity of inactivated 2009 H1N1 influenza vaccine in pediatric liver transplant recipients. Vaccine 2011, 29:4187-4189.
6. Pollyea D.A., Brown J.M.Y., Horning S.J. Utility of influenza vaccination for oncology patients. J Clin Oncol 2010, 28:2481-2490.
7. Kunisaki K.M., Janoff E.N. Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis 2009, 9:493-504.
8. McVernon J., Laurie K., Barr I., Kelso A., Skeljo M., Nolan T. Absence of cross-reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months-9 years: a prospective study. Influenza Other Respir Viruses 2011, 5:7-11.
9. Elder A.G., O'Donnell B., McCruden E.A., Symington I.S., Carman W.F. Incidence and recall of influenza in a cohort of Glasgow healthcare workers during the 1993-4 epidemic: results of serum testing and questionnaire. BMJ 1996, 313:1241-1242.
10. Babcock H.M., Gemeinhart N., Jones M., Dunagan W.C., Woeltje K.F. Mandatory influenza vaccination of health care workers: translating policy to practice. Clin Infect Dis 2010, 50:459-464.